United Therapeutics (UTHR) Earnings Date, Estimates & Call Transcripts $292.01 -5.32 (-1.79%) Closing price 04:00 PM EasternExtended Trading$291.00 -1.01 (-0.35%) As of 06:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock United Therapeutics Earnings Summary United Therapeutics issued Q1 2025 earnings on April 30, 2025, reporting an EPS of $6.63, which beat analysts' consensus estimates of $6.29 by $0.34. Quarterly revenue rose 17.2% year-over-year to $794.40 million, above the consensus estimate of $726.82 million. With a trailing EPS of $25.06 and a P/E Ratio of 11.65, United Therapeutics' earnings are expected to grow 12.30% next year, from $24.48 to $27.49 per share. Upcoming Q2 Earnings DateJul. 30Before Market OpensEstimatedConsensus EPS (Apr. 30) $6.29 Actual EPS (Apr. 30) $6.63 Beat By $0.34 Actual Revenue (Apr. 30) $794.40MQ1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Quarterly Report (10-Q) Press Release (8-K) Slide DeckSEC FilingUTHR Upcoming EarningsUnited Therapeutics' Q2 2025 earnings is scheduled for Wednesday, July 30, 2025, with a conference call scheduled at 9:00 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q2 2025 Earnings ReportSlide DeckFull Screen Slide DeckPowered by Get United Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on United Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataUTHR Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.UTHR Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. United Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20253$6.36$7.07$6.64Q2 20253$6.23$8.08$7.11Q3 20253$6.48$8.50$7.34Q4 20253$6.30$6.75$6.56 FY 2025 12 $25.37 $30.40 $27.64 Q1 20261$6.75$6.75$6.75Q2 20261$6.05$6.05$6.05Q3 20261$6.19$6.19$6.19Q4 20261$5.87$5.87$5.87 FY 2026 4 $24.86 $24.86 $24.86 Q1 20271$5.86$5.86$5.86 United Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 7/30/2025(Estimated)-------4/30/2025Q1 2025$6.29$6.63+$0.34$6.63$726.82M$794.40M2/26/2025Q4 2024$6.10$6.19+$0.09$6.19$734.74M$735.90M10/30/2024Q3 2024$6.16$6.39+$0.23$6.39$722.62M$748.90M7/31/2024Q2 2024$6.33$5.85 -$0.48$5.85$691.87M$714.90M5/1/2024Q1 2024$5.63$6.17+$0.54$6.17$620.31M$677.70M2/21/2024Q4 2023$4.28$4.36+$0.08$4.36$575.01M$614.70M11/1/2023Q3 2023$5.10$5.38+$0.28$5.38$585.82M$609.40M8/2/2023Q2 2023$4.57$5.24+$0.67$5.24$524.18M$596.50M United Therapeutics Earnings - Frequently Asked Questions When is United Therapeutics' earnings date? United Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, July 30th, 2025 based off last year's report dates. Learn more on UTHR's earnings history. Did United Therapeutics beat their earnings estimates last quarter? In the previous quarter, United Therapeutics (NASDAQ:UTHR) reported $6.63 earnings per share (EPS) to beat the analysts' consensus estimate of $6.29 by $0.34. Learn more on analysts' earnings estimate vs. UTHR's actual earnings. How can I listen to United Therapeutics' earnings conference call? The conference call for United Therapeutics' latest earnings report can be listened to online. Listen to Conference Call How can I read United Therapeutics' conference call transcript? The conference call transcript for United Therapeutics' latest earnings report can be read online. Read Transcript How can I view United Therapeutics' earnings report? United Therapeutics' earnings report can be found in their filing with the SEC. View SEC filing How much revenue does United Therapeutics generate each year? United Therapeutics (NASDAQ:UTHR) has a recorded annual revenue of $2.88 billion. How much profit does United Therapeutics generate each year? United Therapeutics (NASDAQ:UTHR) has a recorded net income of $1.20 billion. UTHR has generated $25.06 earnings per share over the last four quarters. What is United Therapeutics' price-to-earnings ratio? United Therapeutics (NASDAQ:UTHR) has a trailing price-to-earnings ratio of 11.64 and a forward price-to-earnings ratio of 11.92. The price/earnings-to-growth ratio is 6.52. What is United Therapeutics' EPS forecast for next year? United Therapeutics' earnings are expected to grow from $24.48 per share to $27.49 per share in the next year, which is a 12.30% increase. More Earnings Resources from MarketBeat Related Companies ALNY Earnings Results BIIB Earnings Results INCY Earnings Results NBIX Earnings Results EXEL Earnings Results BMRN Earnings Results EXAS Earnings Results HALO Earnings Results MDGL Earnings Results RGEN Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Netflix Q2 2025 Earnings: What Investors Need to KnowHow Goldman Sachs Earnings Help You Strategize Your PortfolioCitigroup Earnings Could Signal What’s Next for Markets3 Analysts Set $600 Target Ahead of Microsoft EarningsTesla: 2 Plays Ahead of Next Week's Earnings ReportFastenal Surges After Earnings Beat, Tariff Risks Loom3 Catalysts Converge on Intel Ahead of a Critical Earnings Report This page (NASDAQ:UTHR) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding United Therapeutics Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share United Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free UTHR Stock Alerts